[PDF][PDF] Comprehensive analysis of hypermutation in human cancer

…, DC Bowers, TW Laetsch, GP Dunn, TM Johanns… - Cell, 2017 - cell.com
We present an extensive assessment of mutation burden through sequencing analysis of >81,000
tumors from pediatric and adult patients, including tumors with hypermutation caused …

T-cell exhaustion signatures vary with tumor type and are severe in glioblastoma

…, S Koyama, C Jackson, LJ Hansen, TM Johanns… - Clinical Cancer …, 2018 - AACR
Purpose: T-cell dysfunction is a hallmark of glioblastoma (GBM). Although anergy and
tolerance have been well characterized, T-cell exhaustion remains relatively unexplored. …

[HTML][HTML] The landscape of novel therapeutics and challenges in glioblastoma multiforme: contemporary state and future directions

K Khaddour, TM Johanns, G Ansstas - Pharmaceuticals, 2020 - mdpi.com
Background: Glioblastoma multiforme is a malignant intracranial neoplasm that constitutes a
therapeutic challenge because of the associated high morbidity and mortality given the lack …

Immunogenomics of Hypermutated Glioblastoma: A Patient with Germline POLE Deficiency Treated with Checkpoint Blockade Immunotherapy

TM Johanns, CA Miller, IG Dorward, C Tsien, E Chang… - Cancer discovery, 2016 - AACR
TM Johanns and CA Miller contributed equally to this article. … Training Program at Washington
University School of Medicine (TM Johanns), and an endowment to The Elizabeth H. and …

Considerations for personalized neoantigen vaccination in Malignant glioma

…, N Sherpa, J Manyanga, TM Johanns - Advanced Drug Delivery …, 2022 - Elsevier
Malignant gliomas are the most common primary brain cancer diagnosed and still carry a
poor prognosis despite aggressive multimodal management. Despite the continued advances …

Computational prediction of MHC anchor locations guides neoantigen identification and prioritization

…, S Kiwala, SP Goedegebuure, TM Johanns… - Science …, 2023 - science.org
Neoantigens are tumor-specific peptide sequences resulting from sources such as somatic
DNA mutations. Upon loading onto major histocompatibility complex (MHC) molecules, they …

[HTML][HTML] Regulatory T Cell Suppressive Potency Dictates the Balance between Bacterial Proliferation and Clearance during Persistent Salmonella Infection

TM Johanns, JM Ertelt, JH Rowe, SS Way - PLoS pathogens, 2010 - journals.plos.org
The pathogenesis of persistent infection is dictated by the balance between opposing immune
activation and suppression signals. Herein, virulent Salmonella was used to explore the …

Targeting neoantigens in glioblastoma: an overview of cancer immunogenomics and translational implications

TM Johanns, JA Bowman-Kirigin, C Liu, GP Dunn - Neurosurgery, 2017 - journals.lww.com
Glioblastoma (GBM) remains a disease with a poor prognosis. Unfortunately, over the past
decade, no new treatment options have improved survival in patients beyond the current …

Endogenous neoantigen-specific CD8 T cells identified in two glioblastoma models using a cancer immunogenomics approach

TM Johanns, JP Ward, CA Miller, C Wilson… - Cancer immunology …, 2016 - AACR
TM Johanns and JP Ward contributed equally to this article. … ), and the Physician-Scientist
Training Program at Washington University School of Medicine(TM Johanns and JP Ward). …

Characterization of the genomic and immunologic diversity of malignant brain tumors through multisector analysis

…, JL Dowling, GJ Zipfel, RG Dacey, HC Lu, TM Johanns… - Cancer discovery, 2022 - AACR
This study describes the impact of spatial heterogeneity on genomic and immunologic
characteristics of gliomas and brain metastases. The results suggest that gliomas harbor …